failure to respond or late response
on 08 Aug 2016
Last Applicant/ Owned by
NL-3971 NG Driebergen-Rijsenburg
NL
Serial Number
79178717 filed on 20th Jul 2015
Registration Number
N/A
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Color is not claimed as a feature of the mark. Tissue-regenerative pharmaceutical preparations Scientific research, development and production of artificial tissues by means of tissue engineering; cell cultivation by means of tissue engineering; the aforementioned services also in respect of cartilage Medical services, namely, orthopedic surgery; providing medical information, consultancy and aRead More
Surgical and medical apparatus and instruments for use in orthopedic surgery; artificial cartilage, substitutes for bones, cartilage, ligaments and tendons; bone repair compound for use in orthopedic surgery; orthopedic devices for diagnostic and therapeutic use; medical devices, instruments and aids for cartilage repair; cartilage; implantable living cartilage and cartilage comprised of living tissue
Tissue-regenerative pharmaceutical preparations
Scientific research, development and production of artificial tissues by means of tissue engineering; cell cultivation by means of tissue engineering; the aforementioned services also in respect of cartilage
Medical services, namely, orthopedic surgery; providing medical information, consultancy and advisory services
No 79178717
No Service Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 02th Jul 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 05th Jan 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 21st Sep 2018 | NOTIFICATION PROCESSED BY IB |
| 10th Nov 2017 | REFUSAL PROCESSED BY IB |
| 08th Sep 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 24th Aug 2017 | CHANGE OF OWNER RECEIVED FROM IB |
| 08th Aug 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| 08th Aug 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 18th Apr 2017 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| 31st Mar 2017 | USPTO CORRECTION PROCESSED BY IB |
